Moderate to Severe Atopic Hand and Foot Dermatitis Clinical Trials

Moderate to Severe Atopic Hand and Foot Dermatitis

Explore clinical trials studying Moderate to Severe Atopic Hand and Foot Dermatitis. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Moderate to Severe Atopic Hand and Foot Dermatitis trial results

Completed

A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)

NCT04417894

Conditions: Moderate to Severe Atopic Hand and Foot Dermatitis
Locations: Regeneron Study Site Birmingham, Alabama, United States

Regeneron Study Site Redwood City, California, United States

Regeneron Study Site Washington D.C., District of Columbia, United States

Regeneron Study Site Macon, Georgia, United States

View all 48 locations

View Trial Details